Home/Filings/4/0001493152-22-001759
4//SEC Filing

King-Jones Heidy 4

Accession 0001493152-22-001759

CIK 0001695357other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 5:22 PM ET

Size

17.3 KB

Accession

0001493152-22-001759

Insider Transaction Report

Form 4
Period: 2022-01-18
King-Jones Heidy
Chief Legal Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-18+145,000145,000 total
    Exercise: $4.39Exp: 2032-01-18Common Stock, par value $0.0001 (145,000 underlying)
Footnotes (2)
  • [F1]The options will vest and become exercisable as to 25% on the one-year anniversary of the grant date (January 18, 2023) and the remaining 75% will vest and become exercisable monthly over 36 months such that the options are fully vested and exercisable on the four-year anniversary of the grant date (January 18, 2026).
  • [F2]The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.

Issuer

Provention Bio, Inc.

CIK 0001695357

Entity typeother

Related Parties

1
  • filerCIK 0001794898

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 5:22 PM ET
Size
17.3 KB